D. Baldwin (Nottingham (Nottinghamshire), United Kingdom), I. Rousalova (Praha, Czech Republic), F. Gamarra (Straubing, Germany), C. De Bondt (Antwerpen, Belgium)
Limited role of Ki-67 in lung carcinoid tumor patients predicting overall short-term survival,A single institution experience
K. Krpina (zagreb, Croatia), S. Kukulj (zagreb, Croatia), B. Budimir (zagreb, Croatia), G. Drpa (zagreb, Croatia), L. Bitar (zagreb, Croatia), F. Seiwerth (zagreb, Croatia), B. Cuk (sisak, Croatia), A. Marušic (zagreb, Croatia), J. Grah (zagreb, Croatia), M. Jakopovic (zagreb, Croatia), M. Samaržija (zagreb, Croatia)
|   |
Downregulation of Thyroid transcription factor 1 in lung adenocarcinoma: the prognostic impact
N. Pestana Caires (Lisboa, Portugal), M. Castanho (Lisboa, Portugal), D. Hasmucrai (Lisboa, Portugal), E. Teixeira (Lisboa, Portugal), A. Vilarica (Lisboa, Portugal), P. Alves (Lisboa, Portugal), R. Sotto-Mayor (Lisboa, Portugal)
| |
Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer
L. Schmidt (Muenster, Germany), A. Schulze (Muenster, Germany), B. Heitkoetter (Muenster, Germany), G. Evers (Muenster, Germany), C. Schliemann (Muenster, Germany), K. Steinestel (Muenster, Germany), M. Trautmann (Muenster, Germany), A. Marra (Bremen, Germany), L. Hillejan (Ostercappeln, Germany), E. Wardelmann (Muenster, Germany), K. Rahbar (Muenster, Germany), D. Goerlich (Muenster, Germany), G. Lenz (Muenster, Germany), W. Berdel (Muenster, Germany), W. Hartmann (Muenster, Germany), M. Mohr (Muenster, Germany), S. Huss (Muenster, Germany), R. Wiewrodt (Muenster, Germany)
| |
Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?
F. Bodur Yildirim (Ankara, Turkey), N. Sevimli (Ankara, Turkey), M. TüRk (Kayseri, Turkey), N. YiLmaz Demirci (Ankara, Turkey), A. Yurdakul (Ankara, Turkey), C. öZtüRk (Ankara, Turkey)
| |
Clinical usefulness of natural killer cell activity in patients with non-small cell lung cancer
K. In (Seoul, Republic of Korea), S. Choi (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
| |
Interleukine-17A implicated in survival outcome of patients with late stage lung adenocarcinoma
Y. Huang (Taipei, Taiwan), C. Weng (Taipei, Taiwan), M. Lee (Taipei, Taiwan), C. Wang (Taipei, Taiwan), H. Kuo (Taipei, Taiwan)
| |
Cytotoxicity and apotosis of alveolar lymphocytes (AL) in early clinical stage (I-IIa) of non-small cell lung cancer (NSCLC)
J. Golinska (Bydgoszcz, Poland), P. Kopinski (Bydgoszcz, Poland), E. Wypasek (Kraków, Poland), A. Goede (Bydgoszcz, Poland), K. Szablowska (Bydgoszcz, Poland), M. Gnass (Kraków, Poland), K. Brutkowski (Kraków, Poland), M. Zabczyk (Kraków, Poland), J. Chorostowska (Warszawa, Poland)
| |
The significance of T-box transcription factor 5 and CD44s expression in NSCLC: correlation with prognostic markers.
E. Chaini (Corfu, Greece), A. Athanassiadou (ATHENS, Greece), A. Tsipis (ATHENS, Greece), M. Gonidi (Corfu, Greece), D. Haini (Corfu, Greece), I. Giannopoulos (Corfu, Greece), K. Hainis (Corfu, Greece), P. Athanassiadou (ATHENS, Greece)
| |
Role of carbohydrate metabolism abnormality in non-small cell lung cancer-related immunoparalysis
Z. Komlósi (Budapest, Hungary), G. Szucs (Budapest, Hungary), É. Imre (Budapest, Hungary), M. Szentkereszti (Budapest, Hungary), G. Losonczy (Budapest, Hungary)
| |
Association of tissue inhibitor of metalloproteinases 2 and 3 polymorphisms with non-small cell Lung cancer
Y. Lee (Taichung, Taiwan), C. Shih (Taichung, Taiwan)
| |
Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival.
A. Ali (New Delhi, India), K. Upadhyay (New Delhi, India), V. Kakaria (Bhopal, India), A. Mohan (New Delhi, India), W. Rafi (New Delhi, India), K. Luthra (New Delhi, India), R. Guleria (New Delhi, India)
| |
The NANCI lncRNA-NKX2-1 gene duplex impacts prognosis in stage I NSCLC.
J. Moisés Lafuente (Barcelona, Spain), A. Navarro (Barcelona, Spain), S. Santasusagna (Barcelona, Spain), N. ViñOlas (Barcelona, Spain), J. Ramirez (Barcelona, Spain), G. Frigola (Barcelona, Spain), L. Molins (Barcelona, Spain), J. Castellano (Barcelona, Spain), S. Morales (Barcelona, Spain), C. MuñOz (Barcelona, Spain), M. Monzó (Barcelona, Spain), R. Marrades (Barcelona, Spain)
| |
The CYP2A6 gene polymorphism in male Bataknese smoker lung cancer patients and its association with nicotine dependence
N. Soeroso (Medan, Indonesia), R. Zain-Hamid (Medan, Indonesia), B. Ym Sinaga (Medan, Indonesia), A. Hamid Sadewa (Yogyakarta, Indonesia)
| |
Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases
D. Marinova (Sofia, Bulgaria), D. Kachakova (Sofia, Bulgaria), D. Dimitrova (Sofia, Bulgaria), A. Lilov (Sofia, Bulgaria), E. Mekov (Sofia, Bulgaria), M. Mihailov (Sofia, Bulgaria), S. Giragosyan (Sofia, Bulgaria), Y. Slavova (Sofia, Bulgaria), D. Kostadinov (Sofia, Bulgaria), V. Youroukova (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), A. Mitkova (Sofia, Bulgaria), R. Kaneva (Sofia, Bulgaria), V. Mitev (Sofia, Bulgaria)
| |
Association of Pre-miR-rs2910164 polymorphism with non-small cell lung cancer in an Iranian population
N. K.Dezfoli (Tehran, Islamic Republic of Iran), S. D.Alipour (Tehran, Islamic Republic of Iran), A. Adnan Khosravi (Tehran, Islamic Republic of Iran), J. Garssen (Utrecht, Netherlands), I. Adcock (London, United Kingdom), E. Mortaz (Tehran, Islamic Republic of Iran)
| |
Comparative gene expression analysis in lung cancer
M. Arroyo Varela (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), R. Larrosa Jiménez (Málaga, Spain), R. Bautista Moreno (Málaga, Spain), J. Gómez Maldonado (Málaga, Spain), J. De La Cruz Ríos (Málaga, Spain), L. González Álvarez (Málaga, Spain), C. López Rodríguez (Málaga, Spain), M. Cobo Dols (Málaga, Spain), M. Claros Díaz (Málaga, Spain)
| |
Evaluation of the Thoracic Revised Cardiac Risk Index as a prognostic factor for survival after lung cancer resection
T. Diaz De Teran Lopez (Santander, Spain), C. Magadan Alvarez (Santander, Spain), K. Lee (Auckland, New Zealand), P. Lozano Cuesta (Burgos, Spain), V. Maderuelo Garcia (Palencia, Spain), V. Mora Cuesta (Santander, Spain), D. Iturbe Fernandez (Santander, Spain), B. Abascal Bolado (Santander, Spain), L. Sanchez Moreno (Santander, Spain)
| |
The Khorana score as a predictor of mortality in lung adenocarcinoma
K. Syrigos (Athens, Greece), I. Vathiotis (Athens, Greece), A. Charpidou (Athens, Greece), P. Boura (Athens, Greece), S. Tsimpoukis (Athens, Greece), E. Kokkotou (Athens, Greece), D. Grapsa (Athens, Greece), E. Dimakakos (Athens, Greece)
| |